Characterization of adipose-derived stromal/stem cells from the twitcher mouse model of krabbe disease

BMC Cell Biology

Volumn 14, Issue 1, 2013, Pages

  Zhang, Xiujuan ^a   Semon, Julie A ^a   Zhang, Shijia ^a   Strong, Amy L ^a   Scruggs, Brittni A ^a   Gimble, Jeffrey M ^b   Bunnell, Bruce A ^a,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

Adipose stem cells; ASCs; Autologous transplantation; Krabbe disease; Twitcher mice

Indexed keywords

ALKALINE PHOSPHATASE; BETA1 INTEGRIN; CYTOKINE; MESSENGER RNA; OSTEOCALCIN; STEM CELL ANTIGEN 1; TRANSCRIPTION FACTOR RUNX2; VASCULAR CELL ADHESION MOLECULE 1; GALACTOSYLCERAMIDASE; MEMBRANE ANTIGEN;

ADIPOSE DERIVED STEM CELL; ALKALINE PHOSPHATASE GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CELL SURFACE; COLONY FORMING UNIT; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GLOBOID CELL LEUKODYSTROPHY; IMMUNOREGULATION; MACROPHAGE; MARKER GENE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCALCIN GENE; PROTEIN EXPRESSION; STEM CELL EXPANSION; TRANSCRIPTION FACTOR RUNX2 GENE; WILD TYPE; ANIMAL; BONE DEVELOPMENT; CELL COMMUNICATION; CELL CULTURE; COCULTURE; DISEASE MODEL; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL; STROMA CELL; SUBCUTANEOUS FAT;

MURINAE; MUS;

ANIMALS; ANTIGENS, SURFACE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; GALACTOSYLCERAMIDASE; LEUKODYSTROPHY, GLOBOID CELL; MACROPHAGES; MICE; MICE, MUTANT STRAINS; MUTATION; OSTEOGENESIS; STEM CELLS; STROMAL CELLS; SUBCUTANEOUS FAT;

EID: 84876085816     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-14-20     Document Type: Article

References (45)

1. Suzuki K, Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci USA 1970, 66(2):302-309. 10.1073/pnas.66.2.302, 283044, 5271165.
2. Rafi MA, Zhi Rao H, Passini MA, Curtis M, Vanier MT, Zaka M, Luzi P, Wolfe JH, Wenger DA. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Mol Ther 2005, 11(5):734-744. 10.1016/j.ymthe.2004.12.020, 15851012.
3. Svennerholm L, Vanier MT, Månsson JE. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J Lipid Res 1980, 21(1):53-64.
4. Sakai N. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment. Brain Dev 2009, 31(7):485-487. 10.1016/j.braindev.2009.03.001, 19332366.
5. Suzuki K. Twenty five years of the "psychosine hypothesis" : a personal perspective of its history and present status. Neurochem Res 1998, 23(3):251-259. 10.1023/A:1022436928925, 9482237.
6. Pannuzzo G, Cardile V, Costantino-Ceccarini E, Alvares E, Mazzone D, Perciavalle V. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice. Mol Genet Metab 2010, 100(3):234-240. 10.1016/j.ymgme.2010.03.021, 20418135.
7. Duffner PK, Caggana M, Orsini JJ, Wenger DA, Patterson MC, Crosley CJ, Kurtzberg J, Arnold GL, Escolar ML, Adams DJ. Newborn screening for krabbe disease: the New york state model. Pediatr Neurol 2009, 40(4):245-252. discussion 253-245, 10.1016/j.pediatrneurol.2008.11.010, 19302934.
8. Wenger DA, Rafi MA, Luzi P, Datto J, Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab 2000, 70(1):1-9. 10.1006/mgme.2000.2990, 10833326.
9. Lin D, Donsante A, Macauley S, Levy B, Vogler C, Sands MS. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Mol Ther 2007, 15(1):44-52. 10.1038/sj.mt.6300026, 17164774.
10. Borda JT, Alvarez X, Mohan M, Ratterree MS, Phillippi-Falkenstein K, Lackner AA, Bunnell BA. Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy. Am J Pathol 2008, 172(1):98-111. 10.2353/ajpath.2008.070404, 2189619, 18165263.
11. Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S, Wenger DA, Pietryga D, Wall D, Champagne M. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005, 352(20):2069-2081. 10.1056/NEJMoa042604, 15901860.
12. Duffner PK, Caviness VS, Erbe RW, Patterson MC, Schultz KR, Wenger DA, Whitley C. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley. New York. Genet Med 2009, 11(6):450-454.
13. McGraw P, Liang L, Escolar M, Mukundan S, Kurtzberg J, Provenzale JM. Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements-initial experience. Radiology 2005, 236(1):221-230. 10.1148/radiol.2353040716, 15987975.
14. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 2008, 26(1):212-222. 10.1634/stemcells.2007-0554, 17932417.
15. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24(5):1294-1301. 10.1634/stemcells.2005-0342, 16410387.
16. Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010, 1(2):19. 10.1186/scrt19, 2905095, 20587076.
17. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells-their utility and potential in bone formation. Int J Obes Relat Metab Disord 2000, 24(Suppl 4):S41-S44.
18. Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109(5):656-663. 10.1161/01.CIR.0000114522.38265.61, 14734516.
19. Rangappa S, Fen C, Lee EH, Bongso A, Sim EK, Wei EK. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003, 75(3):775-779. 10.1016/S0003-4975(02)04568-X, 12645692.
20. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7(2):211-228. 10.1089/107632701300062859, 11304456.
21. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13(12):4279-4295. 10.1091/mbc.E02-02-0105, 138633, 12475952.
22. Kim JM, Lee ST, Chu K, Jung KH, Song EC, Kim SJ, Sinn DI, Kim JH, Park DK, Kang KM. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007, 1183:43-50.
23. Gonzalez-Rey E, Gonzalez MA, Varela N, O'Valle F, Hernandez-Cortes P, Rico L, Büscher D, Delgado M. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010, 69(1):241-248. 10.1136/ard.2008.101881, 19124525.
24. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109(10):1292-1298. 10.1161/01.CIR.0000121425.42966.F1, 14993122.
25. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005, 25(12):2542-2547. 10.1161/01.ATV.0000190701.92007.6d, 16224047.
26. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100(9):1249-1260. 10.1161/01.RES.0000265074.83288.09, 17495232.
27. Kobayashi T, Yamanaka T, Jacobs JM, Teixeira F, Suzuki K. The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res 1980, 202(2):479-483. 10.1016/0006-8993(80)90159-6, 7437911.
28. Wenger DA. Murine, canine and non-human primate models of Krabbe disease. Mol Med Today 2000, 6(11):449-451. 10.1016/S1357-4310(00)01800-1, 11074371.
29. Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Curr Opin Orthop 2007, 18:444-448.
30. Kwun IS, Cho YE, Lomeda RA, Shin HI, Choi JY, Kang YH, Beattie JH. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation. Bone 2010, 46(3):732-741. 10.1016/j.bone.2009.11.003, 19913120.
31. Lee AJ, Hodges S, Eastell R. Measurement of osteocalcin. Ann Clin Biochem 2000, 37(Pt 4):432-446.
32. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008, 102(1):77-85. 10.1161/CIRCRESAHA.107.159475, 17967785.
33. Marom R, Shur I, Solomon R, Benayahu D. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol 2005, 202(1):41-48. 10.1002/jcp.20109, 15389528.
34. Contreras MA, Ries WL, Shanmugarajan S, Arboleda G, Singh I, Singh AK. Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease. Biochim Biophys Acta 2010, 1802(7-8):601-608. 2950787, 20441793.
35. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105(7):2821-2827. 10.1182/blood-2004-09-3696, 15591115.
36. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25(11):2739-2749. 10.1634/stemcells.2007-0197, 17656645.
37. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110(10):3499-3506. 10.1182/blood-2007-02-069716, 17664353.
38. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8(9):726-736. 10.1038/nri2395, 19172693.
39. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 2009, 37(12):1445-1453. 10.1016/j.exphem.2009.09.004, 2783735, 19772890.
40. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009, 15(1):42-49. 10.1038/nm.1905, 2706487, 19098906.
41. Dayan V, Yannarelli G, Billia F, Filomeno P, Wang XH, Davies JE, Keating A. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol 2011, 106(6):1299-1310. 10.1007/s00395-011-0221-9, 21901289.
42. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzón IM, Nepomnaschy I, Costa H, Cañones C, Raiden S, Vermeulen M. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 2010, 5(2):e9252. 10.1371/journal.pone.0009252, 2821929, 20169081.
43. Terrell KA, Rasmussen TA, Trygg C, Bunnell BA, Buck WR. Molecular beacon genotyping for globoid cell leukodystrophy from hair roots in the twitcher mouse and rhesus macaque. J Neurosci Methods 2007, 163(1):60-66. 10.1016/j.jneumeth.2007.02.019, 2043377, 17412425.
44. Kumar S, Mahendra G, Ponnazhagan S. Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction. Biochim Biophys Acta 2005, 1731(2):95-103. 10.1016/j.bbaexp.2005.08.007, 16225939.
45. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3(6):1101-1108. 10.1038/nprot.2008.73, 18546601.